HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elke M G J de Jong Selected Research

DNA (Deoxyribonucleic Acid)

1/2005INK4-ARF and p53 mutations in metastatic cutaneous squamous cell carcinoma: case report and archival study on the use of Ink4a-ARF and p53 mutation analysis in identification of the corresponding primary tumor.
5/2003Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elke M G J de Jong Research Topics

Disease

46Psoriasis (Pustulosis Palmaris et Plantaris)
11/2022 - 08/2004
6Inflammation (Inflammations)
10/2021 - 02/2004
6Localized Scleroderma (Morphea)
01/2021 - 12/2008
4Neoplasms (Cancer)
01/2022 - 05/2003
4Psoriatic Arthritis
01/2021 - 03/2010
4Rheumatoid Arthritis
01/2017 - 01/2005
3Eosinophilic Fasciitis
01/2021 - 12/2008
3Infections
12/2014 - 01/2005
2Candidiasis (Moniliasis)
11/2022 - 02/2022
2Rosacea (Acne Rosacea)
02/2022 - 11/2020
2Dermatomyositis (Dermatopolymyositis)
01/2021 - 01/2005
2Crohn Disease (Crohn's Disease)
01/2016 - 01/2011
2Fibrosis (Cirrhosis)
08/2013 - 06/2007
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2009 - 02/2004
2Eczema
01/2009 - 01/2005
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2005 - 05/2003
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
08/2004 - 08/2004
1Cutaneous Candidiasis
02/2022
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Lymphopenia (Lymphocytopenia)
11/2020
1Arthritis (Polyarthritis)
01/2020
1Herpes Zoster
09/2019
1Cardiovascular Diseases (Cardiovascular Disease)
12/2014
1Skin Neoplasms (Skin Cancer)
12/2014
1Disease Progression
10/2014
1Drug-Related Side Effects and Adverse Reactions
08/2013
1Ankylosing Spondylitis
01/2011

Drug/Important Bio-Agent (IBA)

13Adalimumab (Humira)FDA Link
08/2022 - 01/2008
13Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 06/2007
10Biological ProductsIBA
10/2021 - 01/2008
8Etanercept (Enbrel)FDA Link
08/2022 - 01/2013
8Ustekinumab (CNTO 1275)FDA Link
08/2022 - 05/2016
7Pharmaceutical PreparationsIBA
08/2022 - 01/2005
6Infliximab (Remicade)FDA Link
11/2020 - 01/2009
5Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2009
4Interleukin-17 (Interleukin 17)IBA
11/2022 - 01/2021
4AntibodiesIBA
08/2022 - 05/2003
4InterleukinsIBA
02/2022 - 07/2018
4AcitretinFDA Link
11/2020 - 05/2003
3secukinumabIBA
10/2021 - 07/2018
3Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2009
3RetinoidsIBA
08/2004 - 01/2002
2Interleukin-12 (IL 12)IBA
11/2022 - 10/2021
2Ivermectin (Mectizan)FDA Link
02/2022 - 11/2020
2ProteomeIBA
02/2022 - 08/2013
2Interleukin-23 (Interleukin 23)IBA
10/2021 - 01/2021
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 01/2021
2beta-DefensinsIBA
01/2021 - 01/2009
2FumaratesIBA
11/2020 - 05/2016
2Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2020 - 05/2016
2HLA-C Antigens (HLA-C)IBA
01/2019 - 11/2014
2CytokinesIBA
10/2014 - 01/2009
2DNA (Deoxyribonucleic Acid)IBA
01/2005 - 05/2003
2Bexarotene (LGD1069)FDA Link
08/2004 - 08/2004
2TransglutaminasesIBA
08/2004 - 02/2004
1risankizumabIBA
10/2021
1tildrakizumabIBA
10/2021
1guselkumabIBA
10/2021
1ixekizumabIBA
10/2021
1brodalumabIBA
10/2021
1AngiopoietinsIBA
01/2021
1Kallikreins (Kallikrein)IBA
01/2021
1Galectin 1 (LGALS1)IBA
01/2021
1LigandsIBA
01/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1CXC ChemokinesIBA
01/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2021
1CC ChemokinesIBA
01/2021
1Thrombospondin 1IBA
01/2021
1FetuinsIBA
01/2021
1Type II Tumor Necrosis Factor ReceptorsIBA
01/2021
1Genetic Markers (Genetic Marker)IBA
01/2021
1Fibronectins (Fibronectin)IBA
01/2021
1InterferonsIBA
01/2021
1TIE Receptors (TIE Receptor Tyrosine Kinases)IBA
01/2021
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2021
1Peptide Hydrolases (Proteases)FDA Link
01/2021
1Blood Proteins (Serum Proteins)IBA
01/2021
1Interleukin-8 (Interleukin 8)IBA
01/2021
1Interleukin-4 (Interleukin 4)IBA
01/2021
1Interleukin-22 (IL-22)IBA
01/2021
1SteroidsIBA
01/2018
1C-Reactive ProteinIBA
09/2017
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
05/2016
1omega-Chloroacetophenone (Mace)IBA
12/2014
1Interleukin-2 (IL2)IBA
10/2014
1Transferrin (beta 2 Transferrin)IBA
08/2013
1HaptoglobinsIBA
08/2013
1Cadherins (E-Cadherin)IBA
08/2013
1procollagen Type III-N-terminal peptide (PIIP)IBA
08/2013
1inter-alpha-inhibitorIBA
08/2013
1Collagen Type III (Type III Collagen)IBA
08/2013

Therapy/Procedure

19Therapeutics
11/2022 - 08/2004
7Biological Therapy
01/2020 - 03/2010
6Drug Tapering
08/2022 - 01/2017
2Lasers (Laser)
01/2022 - 11/2008
2Phototherapy (Light Therapy)
01/2018 - 12/2008
1Activities of Daily Living (ADL)
01/2022
1Polypharmacy
01/2022
1Duration of Therapy
04/2019